Drug Type Small molecule drug |
Synonyms |
Mechanism CACNA2D1 modulators(Voltage-gated calcium channel alpha2/delta subunit 1 modulators), CACNA2D2 modulators(Voltage-gated calcium channel alpha2/delta subunit 2 modulators), GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H27NO6 |
InChIKeyYDHZNJWFIYERIF-NEPJUHHUSA-N |
CAS Registry1174748-30-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic peripheral neuropathy | Discovery | US | 23 Jan 2009 | |
Epilepsy | Discovery | US | 23 Jan 2009 | |
Fibromyalgia | Discovery | US | 23 Jan 2009 | |
Neuralgia | Discovery | US | 23 Jan 2009 |